Compare Abeona Therapeutics Inc (ABEO) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while KraneShares Electric Vehicles and Future Mobility trades at $30. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.
| ABEO | KARS | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.23 | $38.01 |
52-Week Low | $4.17 | $22.17 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
KARS trades at $31.79, up 1.18% with a bearish technical signal as moving averages indicate selling pressure. The electric vehicle ETF faces industry headwinds including shifting consumer demand and geopolitical tensions affecting fuel prices. Recent news highlights Chinese EV expansion and regulatory uncertainties in the US market, while technical indicators show neutral oscillators but strong bearish momentum from moving averages.
The outlook remains cautious with industry pressures from Chinese competition and regulatory delays. Investment opportunities exist in global EV adoption trends, but risks include tariff policies and demand volatility. Key support sits at $31 with resistance at $32, requiring close monitoring of auto industry developments and policy changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →
